Copper. Copper acts as a coenzyme and affects the synthesis of hormones and neurotransmitters[29], which may take main role in neuroacceleration of bone repair. The musculoskeletal system is the main depot of copper[30]. Copper is a coenzyme in oxidoreductase processes, including collagen formation and normal calcium and phosphorus deposition [30]. Since copper is a coenzyme of lysyl oxidase, a decrease in its level disrupts the formation and cross-linking of collagen molecules, which leads to bone structure disorders and fragility[31]. A study conducted by Li indicates the inhibition of osteoclasts by copper molecules, i.e. a decrease in bone resorption [32]. Moreover, Qi et al. indicate the induction of osteoblast enzymes by copper molecules[33]. At the macrostructural level, the relationship between copper levels, age, and bone strength has been demonstrated in several studies [30; 34]. In our study, serum copper levels increased sharply at 21 days due to release from the bone depot in the group with isolated femoral injury, while bone copper concentration showed an inverse correlation. In general, the bone concentration of copper in case of TBI-related polytrauma was lower than in case of isolated fracture. This phenomenon may be related to the redistribution of the trace element between other bones of the skeleton, since the main copper depot in the body is the ribs and shin bones [30], and the phenomenon of acceleration has systemic nature [8].
Zinc. The function of zinc in osteogenesis is also limited to coenzyme function[30], although bones contain only up to 20% of the total zinc mass. Zinc acts as a coenzyme and regulates gene expression, especially during anabolic processes [35]. The zinc molecule is responsible for the formation of many hormones and hormone-like compounds, including growth factors [30]. This may be the reason for the data on the stimulation of osteoblasts and inhibition of osteoclasts by increased concentrations of the zinc transport protein (ZIP1) [36; 37]. A decrease in bone zinc concentration leads not only to impaired bone reparation but also to a decrease in bone mineral density [38] Again, the increase in bone zinc on day 14 in the poly group with a sharp decrease on day 21, may indicate that the most critical and active period of acceleration is day 14. A similar conclusion was reached by other authors in the histological examination of the bone callus [10, 39]
Cadmium. Although cadmium is better known for its toxicity, its role is to regulate bone resorption [35]. Increased cadmium concentrations reduce bone mineralisation, worsening their physical and mechanical properties [40, 41], causing an osteotoxic effect by inducing osteoblast apoptosis and disrupting the formation of their cytoskeleton [30, 42]. On the other hand, by inducing osteoclast function, cadmium may be one of the markers of the phases of reparative osteogenesis[43]. There are reports of osteoclast activation starting from week 2 in cranio-skeletal polytrauma [16]. The massive release of cadmium into the blood in both groups on day 21 may be caused by osteoclasts activity and, accordingly, bone resorption with the release of trapped cadmium. At the same time, the bone cadmium in polytrauma decreased, which may indicate a more active resorption at the third week.
Magnesium. The effect of magnesium on fusion remains controversial. Some authors point to the falsity of the paradigm about the osteogenic effect of the trace element, pointing to its suppression in the process of hydroxyapatite formation [35]. Magnesium is involved as a coenzyme in more than 300 enzyme systems and energy-dependent cellular functions [30]. It is also an inducer of osteoblast function as a coenzyme in phosphatase enzymes [44, 45]. Since bone tissue is the main dynamic depot of magnesium, changes in its concentration can be a marker of bone repair and mineralisation activity [46]. In our study, the highest concentration of magnesium in both the blood and bone was observed on day 14, which further confirms the statement about the increased activity of bone repair during this period.
Calcium. Calcium plays a major role in mineralisation and is responsible for hard callus formation [30]. The process of remodelling and repair is calcium-dependent due to its direct effect on osteon cells [47]. This trace element is critical for the functioning of the human body, affecting the function of both intra- and extracellular processes [48]. More than 99% of calcium mass is stored in the form of hydroxyapatite [49] Due to its direct involvement in bone remodelling, calcium is one of the markers of bone resorption and osteogenesis[49]. We found a peak increase in calcium concentration on day 14 in the polytrauma group compared to a gradual decrease in the sham group against the background of an increase in serum calcium. This trend may be a marker of significantly more active remodelling of the injured bone in the presence of a cranial component of polytrauma.
The severity of anabolic processes at the level of soft bone regenerate can be indicated by the average concentrations of trace elements that are part of coenzymes - zinc, magnesium and copper. According to the results obtained, it was on day 14 that the bone concentration of copper, zinc and magnesium increased in the case of TBI-related multitrauma. Whereas in the group of animals without TBI, the concentration of these trace elements increased slightly or, on the contrary, decreased during the 14th day. An increase in the activity of anabolic processes in polytrauma after 2 weeks was also observed in Locher's study [5], observing the filling of the osteotomy cavity. In addition, the femur in the polytrauma group showed greater resistance to torsional loads after 3 weeks [50]. The decrease in bone concentrations of copper, zinc and magnesium found in our study against the background of decreased bone mineralisation with calcium in the poly group at 21 days may be a direct cause of the decrease in bone resistance to torsional loads.
Study limitations. It is necessary to take into account the physiological differences in the process and, especially, in the timing of bone regeneration in rodents and humans. The sample size for certain study periods is small, which requires further research using a larger sample size for area of interest. At the stage of study design, we faced a lack of previous studies on the analysis of trace elements in polytrauma, especially in humans. Exactly why representativeness may be one of the study limitations. Great care should be taken when applying the results of this study in the clinic.